Selection and characterization of murine monoclonal antibodies to Staphylococcus aureus iron-regulated surface determinant B with functional activity in vitro and in vivo.
about
The Role of Staphylococcus aureus Virulence Factors in Skin Infection and Their Potential as Vaccine AntigensInvestigational drugs to treat methicillin-resistant Staphylococcus aureusCovering all the Bases: Preclinical Development of an Effective Staphylococcus aureus VaccineFour-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice.In silico analysis for identifying potential vaccine candidates against Staphylococcus aureus.Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis modelExploring Staphylococcus aureus pathways to disease for vaccine development.Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia modelsStaphylococcus aureus vaccines: Deviating from the carolNaturally occurring IgG antibody levels to the Staphylococcus aureus protein IsdB in humans.Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines.Challenges for a universal Staphylococcus aureus vaccine.Recent developments in understanding the iron acquisition strategies of gram positive pathogens.Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.An integrated approach to epitope analysis II: A system for proteomic-scale prediction of immunological characteristics.Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB).Antibody-Based Agents in the Management of Antibiotic-Resistant Staphylococcus aureus Diseases.Protective humoral and CD4+ T cellular immune responses of Staphylococcus aureus vaccine MntC in a murine peritonitis model.
P2860
Q26768436-29EB3C5E-80C2-4B34-BEE4-615A4B7EF92FQ26780246-6F1425E8-5CF9-424D-8D00-F654B2B01E8EQ27008338-1D5F1F6B-9B49-4F16-9469-1B1142C5B62CQ34478033-B3681FE2-1C0C-4818-8F70-AC3589E8BF33Q35035639-AD2781FF-9DD8-4E0C-A53D-8A632DF0A62FQ36184397-6896E3CE-6E9F-456E-9E47-EFB3D95676D0Q36516970-CEF981A6-2575-442A-BC11-2A62A2C7B985Q36569841-D8C91B8C-723C-441A-A41F-494C09FEE608Q37197990-EA9E43DB-45A9-4BBD-974B-6939F8CB9BA9Q37530311-71AC65FB-AE86-41B3-9E7B-42AC732AB13FQ37878489-9D41A3B1-7D5D-4C58-AAC1-10C55D180D23Q37987099-E47DDC94-4397-495F-8DDF-4B664F916036Q38415707-00CB127B-4E6A-4DFE-AAE7-DE952952991FQ41117685-033AFD1D-04E0-4C60-8641-32C30D49F65EQ41544046-0ADC3B5B-6D76-4467-AD2B-4AA912E6317FQ42210682-380028A5-BFED-480D-81C5-11100E667C7CQ53702468-B134C6B1-5E49-4C45-9FD4-0B67E0806177Q53706343-A880C051-9C71-4601-900C-C0CFC9571527
P2860
Selection and characterization of murine monoclonal antibodies to Staphylococcus aureus iron-regulated surface determinant B with functional activity in vitro and in vivo.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Selection and characterization ...... activity in vitro and in vivo.
@en
Selection and characterization ...... activity in vitro and in vivo.
@nl
type
label
Selection and characterization ...... activity in vitro and in vivo.
@en
Selection and characterization ...... activity in vitro and in vivo.
@nl
prefLabel
Selection and characterization ...... activity in vitro and in vivo.
@en
Selection and characterization ...... activity in vitro and in vivo.
@nl
P2093
P2860
P356
P1476
Selection and characterization ...... activity in vitro and in vivo
@en
P2093
Annaliesa S Anderson
Donna Montgomery
Greg Pancari
Julie Zorman
Kevin Isett
Leslie Cope
Martha Brown
Qinjian Zhao
Rose Kowalski
Susan Secore
P2860
P304
P356
10.1128/CVI.00085-09
P577
2009-06-24T00:00:00Z